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ABSTRACT
Introduction: Cancer-patients undergoing chemotherapy experience a high level of depression. The objective of this 
study was to determine the prevalence and predictors of depression in cancer-patients receiving chemotherapy in 
government hospitals in Peninsular Malaysia. Methods: This research was started with a cross-sectional study among 
1356 patients undergoing chemotherapy in 10 government state hospitals in the Peninsular Malaysia. The data were 
collected using self-administered questionnaires including socio-demographic characteristics, severity of cancer, 
depression through Patient Health Questionnaire (PHQ-9), social support using the Multidimensional Scale of Per-
ceived Social Support (MSPSS) and hopelessness using the Beck Hopelessness Scale (BHS).The research also con-
ducted the descriptive statistics to obtain variable percentages and frequencies. Inferential analysis was also conduct-
ed by using chi-square or Fisher’s exact test in determining the relations among variables at the level of significance 
where p<0.05.Simple logistic regression was applied in determining the crude odd-ratio and variables with p value, 
where p<0.25, were entered into the multivariate logistic regression model to identify the significant predictors of 
depression. The best predictor was based on adjusted odds ratio.  Results:The prevalence of depression was 34.00%. 
The significant predictors of depression were age, gender, education level, pain due to chemotherapy, depressed due 
to cancer, treatment with any anti-depressant, worried of the adverse effect due to cancer treatment, involvement in 
any cancer support society, level of social support and level of  hopelessness. Among all predictors, level of social 
support was identified as the highest risk of prediction for depression. Conclusion: Findings of the study indicate that 
the health care services should focus on the management and intervention of depression in cancer-patients. 
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INTRODUCTION
Cancer is a global public health concern. Cancer occurs 
when our cells begin to reproduce in an uncontrollable 
manner. Once cancer has manifested, it eventually 
spreads to other parts of the body. The consequences 
of cancer are various with the most severe being death 
(1).Till now, about 14.1 million new cases of cancer 
were reported with 8.2 million cancer deaths and 32.6 
million are living with cancer diagnosis for the period 
of 5 years (2). In terms of the burden of disease, the 
number of cancer cases, deaths, and disability-adjusted 
life-years (DALYs) are 14.9, 8.2, and 196.3 million, 
respectively (3). In Malaysia, cancer has been as one 
among the top five causes of death (4). In year 2014, 
cancer death was higher in males with 11,200 deaths 
compared to females with 10,300 deaths (5). Cancer 
patients, who are undergoing chemotherapy, normally 
experience a greater level of depression (6). Cancer 
patients have depression due to many reasons such as 
reaction to cancer diagnosis, symptoms associated with 
cancer and worrying about the progression of cancer. 
Besides that, radiotherapy and chemotherapy treatment 
for cancer patients also contributes to the depression 
(7). In some cases, depression experienced by patients 
after the diagnosis of cancer is more adaptable because 
patients have better understanding about the symptoms 
and treatment of cancer. Depression is a state of mental 
disorder and the usual signs of depression are tiredness, 
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loss of appetite, depressed mood and followed by 
sadness (1). Clinical depression is a serious illness as 
it can cause patients to feel distressed and it is harder 
for a patient to function as well as to follow treatment 
plans. Individuals who suffer from depression even 
prior to diagnosis of cancer are more likely to have 
suicidal thoughts (8). Depression is common both 
in cancer patients and among the immediate family 
members (9). Several studies have been conducted on 
depression among cancer patients in Malaysia focusing 
specifically on certain types of cancer and study 
locations (example of locations are University Malaya 
Medical Centre, Kuala Lumpur, University Kebangsaan 
Malaysia Medical Center, Kuala Lumpur and Hospital 
Sultanah Bahiyah, Alor Star) (6, 10, 11, 12). However, 
to our understanding there is still lack of information 
regarding the prevalence and predictors of depression 
among oncology patients undergoing chemotherapy. 
We therefore intend to investigate the prevalence and 
predictors of depression among oncology patients 
who are receiving chemotherapy in government state 
hospitals in Peninsular Malaysia. This study provides 
information on prevalence and predictors of depression 
among chemotherapy patients in Peninsular Malaysia. 
Other than that, this study enhances our understanding 
of the relationship between chemotherapy and how 
it affects depression. The outcome of this study 
benefits the pharmacists to counsel oncology patients 
accordingly and provide proper information regarding 
disease, treatment, and factors related with depression 
among cancer patients. Researchers and staffs in 
clinical settings can use the outcome of this research in 
preparation of intervention programs for cancer patients 
with depression.
 
MATERIALS AND METHODS
Study design and location
A cross-sectional research study was conducted from 
April to August 2016.This research focused on 1356 
cancer patients who were undergoing chemotherapy 
treatment in oncology wards and daycare units of 10 
government state hospitals throughout the Peninsular 
Malaysia. The inclusion criteria was Malaysian citizens 
who were receiving chemotherapy as cancer patients 
and the exclusion criteria were patients who were too 
ill to participate in this study, patients with hearing and 
speech difficulties and patients who had any psychotic 
features. 
Sample size
Sample size was calculated by using the formula from a 
two-group comparison as presented by Lemeshow et al., 
(1990). The sample size calculated was 1356.
Sampling technique
Ten government hospitals were selected based on 
the highest number of chemotherapy patients using 
cluster sampling. For the selection of patients from 
each hospital, sampling with probability proportional 
to size was applied. The list of patients undergoing 
chemotherapy was obtained from the pharmacy-in-
charge of the cytotoxic drug reconstitution (CDR) unit. 
All the patients in the list were included in this study.
Instruments
For the data collection, a self-administered validated and 
pretested questionnaire was used. The questionnaires 
were in Malay and English languages. There were four 
sections in the questionnaire:
Section A (Socio demographic characteristics and 
severity of cancer)
This section includes the questions regarding socio 
demographic characteristics and severity of cancer. Socio 
demographic characteristics consist of respondents’ age, 
gender, ethnicity, religion, marital status, family member 
living together, education level, family history of cancer, 
pain due to chemotherapy, if patient is depressed due 
to cancer, treating with any anti-depressant, if patient 
is worried of the chemotherapy adverse effects and if 
patient has joined any cancer support society. Severity 
of cancer consists of stage of cancer and number of 
chemotherapy cycle.
Section B (PatientaHealthaQuestionnairea[PHQ-9])
This section consisted of questions on depression which 
was detected using the Patient Health Questionnaire 9 
(PHQ-9). This questionnaire consisted of nine items and 
the score ranged from 0-27. There were four choices in 
the PHQ-9 which were scored as follows: 
• 0-for “Not at all”
• 1-for “Several days”
• 2-for “More than half the days”
• 3-for “Nearly every day”
A threshold score of 0-4 was considered to indicate none 
to minimal depression, 5-9 indicated mild depression, 
10-14 indicated moderate depression, 15-19 indicated 
moderately severe depression, and 20-27 indicated 
severe depression (13). The PHQ-9 was found as, 
reliable and valid tool (14). Assessment on the severity of 
depression using the PHQ-9-in-cancer-patients-and-the-
general population has-shown that the scale was reliable 
among cancer patients (Cronbach’s alpha ≥ 0.84) (15). 
The PHQ-9 scale showed effective results in screening 
lung cancer patients in busy outpatient settings (16). 
PHQ-9 was found to be valid, reliable, and a responsive 
depression measure in adults with cancer and also 
freely available to use (17). The Malay version of PHQ-9 
has been validated in primacy care clinics in Malaysia 
among 895 participants with sensitivity 87.00% and 
specificity 82.00%. The cutoff point of 10 and above 
was used in PHQ-9 (18). In this study, a cut-off point of 
10 and above was used.
Section C (Beck Hopelessness Scale [BHS])
The Beck Hopelessness Scale (BHS) was used in this 
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process was provided in the information sheets given to 
them. The researcher who was present throughout the 
data collection provided further explanation verbally. 
Written consent was also obtained from the respondents 
before the collection of data. All the respondents were 
well informed that they have a choice to retract their 
participation from this research at any time. Permission 
for the questionnaires used in this research was obtained 
from the respective authors.
Data Analysis
Data were collected using self-administered 
questionnaires including socio-demographic 
characteristics, severity of cancer, depression, social 
support and hopelessness. Data were analyzed by using 
SPSS (Statistical Package for Social Sciences) software 
Version 22.0. Descriptive statistical analysis was 
conducted to obtain the percentage and frequency of 
variables. Inferential analysis was conducted by using 
chi-square or Fisher’s exact test to identify the relation 
among variables at the significance level where p<0.05. 
Simple logistic regression was used to determine the 
crude odd ratio and variables with p value<0.25 were 
entered into the multivariate logistic regression model 
to determine significant predictors of depression. The 
results were interpreted based on the obtained adjusted 
odds ratio and p-value. The best predictor was based on 
adjusted odds ratio. When the odds ratio was greater than 
1, it described a positive relationship.A p-value less than 
0.05 (p<0.05) was considered statistically-significant. 
The Nagelkerke R Square, Hosmer-and-Lemeshow 
Test, classification table and area under the Receiver-
Operating-Characteristic (ROC) curve were shown 
in this study. The value-of Nagelkerke R-Square was 
reported to show the amount of variation in depression 
that was explained by the model. Meanwhile -for 
Hosmer -and Lemeshow-Test, p-value more than 0.05 
showed that the model was “fit”. The classification table 
indicated the ability of the model to predict the correct-
category for depression (Yes or No) for each case. The 
area under the ROC curve was used to measure the 
model discrimination. 
RESULTS
Out of 1356 respondents, all respondents participated in 
this study, giving an overall response rate of 100.00%. 
Majority of the respondents were female (57.00%). 
Approximately half of the respondents were Malays 
(43.20%), followed by Chinese (37.00%), Indians 
(16.40%), and others (3.30%). ‘Others’ consisted of Sikh, 
Kadazan and Iban.  Majority (44.00%) of the respondents 
were Muslims, followed by Buddhists (35.60%), Hindus 
(10.70%), Christians (7.20%), others (2.20%) and no 
religion (0.30%). Majority of the respondents were 
married (37.20%) followed by widowed (32.70%), single 
(15.60%), divorced (8.50%) and separated (6.00%).The 
results showed that 29.50% received primary education 
and 25.70% received no education. Only 38.90% 
study to measure hopelessness in three major aspects, 
such as feelings about the future, loss of motivation, 
and expectations (19). The questionnaire consisted of 
twenty items. Hopelessness among the respondents 
was determined using the cut-off point of nine. The 
respondents answered “True” for the statement that 
best described their attitude for the past week including 
the day they answered the questionnaire and if the 
statement did not describe their attitude, the respondents 
answered “False”. This scale’s internal consistency 
ranged from 0.8-0.9 and its test-retest scores was 0.7 
(19). For the Malay version of Beck Hopelessness Scale, 
minimal translation was done without validity of the 
questionnaire. 
Section D (Multidimensional Scale of Perceived Social 
Support [MSPSS])
This section contained questions on social support 
perceived by patients. Social support was detected using 
the Multidimensional Scale of Perceived Social Support 
(MSPSS).
This questionnaire consisted of twelve items and the 
scores ranged from 12-84. There were seven choices in 
the MSPSS which were scored as follows: 1 for “Very 
strongly disagree”, 2 for “Strongly disagree”, 3 for 
“Mildly disagree”, 4 for “Neutral, 5 for “Mildly agree”, 
6 for “Strongly agree” and 7 for “Very strongly agree”. 
The score of 69 to 84 indicated high social support, 
49 to 68 indicated moderate social support and 12 to 
48 indicated low social support (20).The validation for 
MSPSS Malay version was done in University Malaya’s 
Medical Faculty among 237 students (21). A good 
internal consistency was shown by this instrument 
(Cronbach’s alpha is 0.89), parallel form reliability as 
0.94, and test–retest reliability as 0.77 (Spearman’s rho, 
p < 0.01). Meanwhile the reliability coefficients for 
family, friends and significant others are 0.88, 0.82 and 
0.94 (21).
Reliability of Questionnaire (Cronbach alpha)
The data collected during the pretesting were analysed 
to check for internal consistency of the questionnaire 
where a Cronbach alpha coefficient value was used 
to determine the reliability of the questionnaire. All 
questionnaires showed high reliability with Cronbach 
alpha value of 0.7 and above.
Ethics Approval
Approvals were obtained from the Medical Research 
and Ethics Committee (MREC) and Ethics Committee 
for Research Involving Human Subjects Universiti Putra 
Malaysia prior to data collection. The approval from 
MREC was obtained using the registration of the national 
study. This study was a baseline study for the national 
study. Permission was also obtained from Hospital 
Directors, Heads of Pharmacist Departments and 
pharmacists in-charge CDR units. As for the respondents, 
explanation of the study objectives and data collection 
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received secondary education, while 5.90% received 
a university education. The higher respondents were at 
the 4th stage of cancer which was 28.50%. A majority 
(39.50%) of respondents were undergoing 3rd cycle of 
chemotherapy. Majority of the respondents were not 
treated with any anti-depressant (82.70%). The results 
also show that 61.10% of the respondents were worried 
about the adverse effect due to cancer treatment. Out 
of 1356 respondents, only 672 respondents joined any 
cancer support society. Majority of the respondents 
had medium support (37.80%). A total of 62.30% 
of respondents had feelings of hopelessness (mild= 
24.50%, moderate=26.40% and severe=11.40%).The 
prevalence of depression among oncology patients 
receiving chemotherapy were 34.00%. 
Based on Table I, Table 11 and Table III, age, gender, 
marital status, family members living together, education 
level, stage of cancer, number of chemotherapy cycle, 
family history of cancer, pain due to chemotherapy, 
depressed due to cancer, treatment with any anti-
depressant, worried of the adverse effect due to cancer 
treatment, involvement in any cancer support society, 
level of social support and hopelessness were found to 
be statistically significantly associated with depression 
(p<0.05).
In the simple logistic regression for depression, all 
of the 15 factors were selected based on p<0.25 for 
multivariate analysis. All these factors were entered into 
the multivariate logistic regression models to identify 
the significant predictors. Out of these 15 factors, only 
ten factors were selected using the stepwise selection 
method to identify the predictors for depression. 
According to Table IV, the best predictor for depression 
was level of social support. Respondents with low level 
of social support compared to respondents with medium 
or high levels of social support were 6.680 times more 
likely to have depression (AOR 6.680, 95% CI 4.815 to 
9.269). 
The value of Nagelkerke R square was 0.490. Hosmer 
and Lemeshow test indicated that this model was fit 
(p=0.082). Based on the classification table, 79.60% of 
cases were classified correctly. Figure 1 showed the area 
under the ROC curve was found to be 0.871 (95% CI 
0.852 to 0.889, p<0.001), which means that the model 
is able to discriminate 87.10% of the cases in this study.
DISCUSSION
Response rate
The response rate of this study was 100.00%; which 
was similar to the response rate in a study done among 
283 elderly African American cancer patients on the 
predictors of depression (22).
Table I: Association between socio-demographic characteristics and 
depression (N=1356)
Variables Depression (PHQ-9)
Yes No Total x² df p-value
Age
≤60 229 (28.00%) 589 (72.00%) 818 33.099 1 <0.001**
>60 232 (43.10%) 306 (56.90%) 538
Total 461 (34.00%) 895 (66.00%) 1356
Gender
Male 161(27.60%) 422(72.40%) 583 18.559 1 <0.001**
Female 300(38.80%) 473(61.20%) 773
Total 461(34.00%) 895(66.00%) 1356
Ethnicity
Malay 200(33.30%) 401(66.70%) 601 0.249 1 0.618
Non-Malay 261(34.60%) 494(65.40%) 755
Total 461(34.00%) 895(66.00%) 1356
Religion
Muslim 203(33.20%) 409(66.80%) 612 0.340 1 0.560
Non-Muslim 258(34.70%) 486(65.30%) 744
Total 461(34.00%) 895(66.00%) 1356
Marital status
0.016*
Single 387(35.50%) 702(64.50%) 1089 5.846 1
Married 74(27.70%) 193(72.30%) 267
Total 461(34.00%) 895(66.00%) 1356
Family 
member living 
together
Living alone 28(47.50%) 31(52.50%) 59 4.981 1 0.026*
Living with 
someone
433(33.40%) 864(66.60%) 1297
Total 461(34.00%) 895(66.00%) 1356
Education
Educated 309(30.70%) 699(69.30%) 1008 19.553 1 <0.001**
Non-educated 152(43.70%) 196(56.30%) 348
Total 461(34.00%) 895(66.00%) 1356
* Significant at p <0.05        **Significant at p <0.001
Prevalence of Depression
The study found that the prevalence of depression in 
oncology patients receiving chemotherapy was 34.00%. 
Based on a research carried out on the prevalence of 
depression among patients with newly diagnosed 
advanced gastrointestinal cancer using the Patient Health 
Questionnaire-9 (PHQ-9), 25.80% of the respondents 
showed high levels of depression (23). A cross-sectional 
study was conducted in Thailand to determine the 
prevalence of depression among cancer patients by 
using the Patient Health Questionnaire-9 (PHQ-9) 
with a cut off score of 10. Among the 108 patients, 
32 patients (29.60%) were classified in the depressive 
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Table II: Association between socio-demographic characteristics and 
severity of cancer with depression (N=1356)
Variables Depression (PHQ-9)
Yes No Total x² df p-value
Stage of 
cancer
1 and 2 247(36.90%) 422(63.10%) 669 5.030 1 0.025*
3 and 4 214(31.10%) 473(68.90%) 687
Total 461(34.00%) 895(66.00%) 1356
Number of chemotherapy cycle
1 and 2 198(37.50%) 330(62.50%) 528 4.729 1 0.030*
3 and more 263(31.80%) 565(68.20%) 828
Total 461(34.00%) 895(66.00%) 1356
Family history of cancer
Yes 298(32.20%) 627(67.80%) 925 4.113 1 0.043*
No 163(37.80%) 268(62.20%) 431
Total 461(34.00%) 895(66.00%) 1356
Pain due to chemotherapy
Yes 345(44.10%) 437(55.90%) 782 84.326 1 <0.001**
No 116(20.20%) 458(79.80%) 574
Total 461(34.00%) 895(66.00%) 1356
Depressed due to cancer
Yes 347(44.20%) 438(55.80%) 785 86.550 1 <0.001**
No 114(20.00%) 457(80.00%) 571
Total 461(34.00%) 895(66.00%) 1356
Treating  with any  anti-depressant
Yes 102(43.60%) 132(56.40%) 234 11.597 1 <0.001**
No 359(32.00%) 763(68.00%) 1122
Total 461(34.00%) 895(66.00%) 1356
Worried of the adverse effect due to cancer treatment
Yes 390(47.10%) 438(52.90%) 828 162.737 1 <0.001**
No 71(13.40%) 457(86.60%) 528
Total 461(34.00%) 895(66.00%) 1356
Involvement in  cancer support society
Yes 159(23.70%) 513(76.30%) 672 63.431 1 <0.001**
No 302(44.20%) 382(55.80%) 684
Total 461(34.00%) 895(66.00%) 1356
* Significant at p <0.05         **Significant at p <0.001
Table III: Association between level of social support and level of 
hopelessness with depression (N=1356)
Variables Depression (PHQ-9)
Yes No Total x² df p-value
Level of social 
support
Low 
234
(62.40%)
141
(37.60%)
375 186.356 1 <0.001**
Medium High 227
(23.10%)
754
(76.90%)
981
Total 461
(34.00%)
895
(66.00%)
1356
Level of hope-
lessness
No
Yes
Total
61
(11.80%)
400
(47.80%)
461
(34.00%)
458
(88.20%)
437
(52.20%)
895
(66.00%)
519
837
1356
185.400 1 <0.001**
* Significant at p <0.05       **Significant at p <0.001
Figure 1:  Assessment of model discrinimation by area under 
the ROC Curve for depression
category, where 16 patients (50.00%) experienced mild 
depression, six (18.80%) had moderate depression, and 
10 (31.20 %) had severe depression (24). Meanwhile, 
in Malaysia, a study done on the prevalence of 
depression among gynaecological cancer patients at 
Hospital Bahiyah, Alor Star, Malaysia showed that the 
prevalence of depression was 18.00% which was higher 
than the general populations (11). The differences in the 
prevalence could be due to the number of sample size. 
Factors associated with depression among the 
respondents
I. Association between socio-demographic 
characteristics and severity of cancer with depression 
among the respondents
There were significant associations between age, gender, 
marital status, family members living together, education 
level, stage of cancer, number of chemotherapy cycle, 
family history of cancer, pain due to chemotherapy, 
depressed due to cancer, treatment with any anti-
depressant, worried of the adverse effects due to cancer 
treatment, involvement in cancer support society, level 
of social support and hopelessness with depression.
a) Age
In this study, patients with age more than 60 years old 
were more prevalent to depression when compared to 
those ages 60 years and below (p<0.001). The results 
were similar to other findings between age and depression 
studies (25, 26).The results showed elderly patients were 
more at risk of depression (26). Furthermore, elderly 
patients with cancer experience depressive syndrome, 
which leads to a high risk of committing or attempting 
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Table IV: Predictors of depression among the respondents
Variables B S.E. Wald df p-value AOR 95% CI for AOR
Lower Upper
Age
≤60 1
>60 0.431 0.150 8.304 1 0.004 1.539 1.148 2.064
Gender
Male 1
Female 0.695 0.157 19.712 1 <0.001 2.004 1.475 2.725
Education
Educated 1
Non-educated 0.485 0.165 8.646 1 0.003 1.625 1.176 2.245
Pain due to chemotherapy
No 1
Yes 0.856 0.164 27.308 1 <0.001 2.354 1.708 3.246
Depressed due to cancer
No 1
Yes 1.215 0.173 49.507 1 <0.001 3.369 2.402 4.725
Treating with any anti depressant
No 1
Yes 0.808 0.201 16.181 1 <0.001 2.244 1.514 3.328
Worried of the adverse effect due to cancer treatment
No 1
Yes 1.173 0.186 39.648 1 <0.001 3.232 2.243 4.657
Involvement in cancer support society
Yes 1
No 0.670 0.155 18.756 1 <0.001 1.954 1.443 2.646
Level of social support
Medium High 1
Low 1.899 0.167 129.194 1 <0.001 6.680 4.815 9.269
Level of hopelessness
No 1
Yes 1.268 0.190 44.479 1 <0.001 3.555 2.449 5.161
suicide. Old age increases the period of disease, greater 
probability of cancer metastasis, and higher disability 
risks (26). These conditions worsen the depression 
among elderly patients (26).
b) Gender
Females were more prevalent to depression when 
compared to males (p<0.001). In a study conducted by 
Polikandriotiet al., (2008) on evaluation of depression in 
patients undergoing chemotherapy showed that females 
experienced higher depression than males but there 
were no significant statistics (26).Similarly, a significant 
prevalence of depression among female as compared 
with male among 4020 adult cancer inpatients and 
outpatients in Germany (p<0.001) (25). 
c) Marital status
In this study, single women were more prone to 
depression compared to women who were married. 
This result is similar to a study where widowed women 
(19.00%) or divorced/separated/single (16.00%) were 
more likely depressed compared to married women 
(12.00%) (27). Results from a prospective study also 
found that those being single were more likely to have 
depression (p= 0.001) (28). Moreover, married women 
were anxious due to responsibilities of caring for their 
families which are the biggest commitments in their 
lives. While women who are single are likely to be 
depressed from fear of losing their partner and friends 
due to their health conditions (10).
d) Family members living together
Patients living together with family members were 
more prevalent to depression as compared to those 
living alone (p=0.026).These findings are supported by 
Hassan et al.’s study, (2015) which showed that there 
was a significant association. Moreover, respondents 
who have family members living together will be more 
worried and fear about their health and deaths which 
will bring more difficulties to their family as their disease 
prolong (10).
e) Education level
Educated respondents had a significantly less 
prevalence to depression compared to respondents 
without education (p<0.001). This finding is supported 
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by Polikandrioti et al’s study (2008) which showed that 
patients with only primary level education experienced 
significantly higher depression compared to those with 
secondary and/or tertiary education (p<0.001). This was 
because patients with lower level of education were 
reluctant to report their symptoms of depression and 
they regarded chemotherapy and its side-effects as more 
significant. Inspite of their reluctance, the prevalence 
was still high. Therefore, the prevalence may actually 
be much higher than those reported. Patients with 
low education and who were economically unstable 
sought advice and care when the disease had reached 
advanced stage (26).
f) Stage of cancer
Stages of cancer had significant association (p=0.025) 
with depression. In this study, stage one and stage 
two cancer patients were more prone to depression 
compared to patients in stage three and stage four. These 
findings were supported by a proportional stratified 
random sample by using the PHQ-9 questionnaire 
where a significant relation were found among the 
stages of cancer with depression (p<0.001) (25).Similar 
results obtained by several other studies also showed 
significant association between the stage of cancer and 
depression (29, 30). Stage two cancer patients were 
more prone to depression compared to patients in 
stage three and above because patients in early stage 
of cancer is unable to manage emotional distress which 
will significantly worsen the quality outcome in cancer 
treatment (30). 
g) Number of chemotherapy cycles
This study also found significant association between 
the number of chemotherapy cycles (p=0.030) with 
depression among the respondents. In this study, the 
majority of respondents (68.20%) undergoing 3 and 
more chemotherapy cycles did not have depression. 
This result was similar to another finding between 
number of chemotherapy cycles and depression (31).
h) Family history of cancer
This study found that the respondents with family history 
of cancer were more prone to depression. Family history 
of cancer was significantly associated (p=0.043) with 
depression. These findings are supported by a study 
done by Khalil et al (2016),which showed that there was 
an association between the occurrence of cancer in the 
family (p=0.047) and depression.
i) Pain due to chemotherapy
Pain due to chemotherapy was found as a significant 
predictor of depression in this present study (p<0.001). 
The results from the present study was comparable to a 
study that was conducted among 120 gynaecological 
cancer patients which found that physical pain was 
associated with Major Depressive Disorders (MDD) in 
gynaecological cancer patients (p<0.001) (11).Physical 
pain can precipitate or perpetuate MDD in cancer 
patients either from the cancer itself or the side effects of 
treatment(11).Another study done by Khalil et al (2016) 
showed that depression was found to be significantly 
associated with severity of pain (p<0.001).
j) Depressed due to cancer
Respondents who thought they themselves were 
depressed due to cancer were found to be significant 
predictors of depression in this present study (p<0.001). 
These results from the present study were comparable to 
a cross-sectional study done by Khalil et al (2016) which 
showed that there was an association between feeling 
depressed due to cancer with depression (p=<0.001). 
It was also stated that proper counseling will help in 
relieving their thoughts that they were depressed may 
lower their depression level (32).
k) Treatment with any anti-depressant
Treatment with any anti-depressant was significantly 
associated with depression (p<0.001). While some 
patients treated with anti-depressants still had depression, 
most of the respondents were not treated with any anti-
depressant which causes increase in depression level 
(32.00%). This finding is supported by a study done 
by Khalil et al (2016) which showed that there was an 
association between respondents seeking treatment for 
their depression with depression (p=0.019). Another 
study done by Polikandrioti et al (2008) showed that 
only 13 respondents were treated with anti-depressants 
and there was an association between pharmaceutical 
therapy with depression (p=0.001).  
l) Worried of the adverse effects due to cancer treatment
This study found that being worried of the adverse 
effects due to cancer treatment was significantly 
associated with depression (p<0.001). In the present 
study, most of the respondents were worried about 
the adverse effects due to cancer treatment (47.10%). 
This finding is supported by a study done by Chan and 
Ismail (2014) which showed that among all symptoms, 
patients were basically worried about vomiting 
(33.30%), loss of appetite (23.30%), nausea (16.70%), 
hair loss and numbness (10.00%). The majority of 
patients (86.70%) believed that all the symptoms were 
overlooked by the healthcare providers (33).Another 
study done by Chintamani et al. (2011) found that after 
the chemotherapy cycles patients were mostly worried 
about the side-effects such as nausea and alopecia.
m) Joined any social support society
This study found that the respondents who had joined 
any social support society were significantly associated 
with depression (p<0.001). In the present study, most 
of the respondents did not join any social support 
society (44.20%) which led to depression. This finding 
is supported by a study done by Maneeton et al (2012), 
using the PHQ-9, which showed that the support system 
was significantly associated with depression (p=0.024). 
Cancer patients were significantly more prone to 
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depression when they had no support system, and had 
pain and depression which lead to suicidal thoughts 
(24).
II. Association between level of social support and 
depression among the respondents
This study found a significant association between 
the level of social support (p<0.001) and depression. 
These findings are supported by a cross-sectional 
descriptive study where perceived social support was 
proven in predicting MDD (11).When diagnosed with 
cancer, mental and family supports were even more 
important to lessen the depression and psychological 
distress. Friends, family members, and relatives can 
support through companionship, comfort, and sense of 
security to cancer patients. These were crucial factors 
for buffering emotional distress, as well as preventing 
and treating MDD (11). In another study done by Ng 
et al (2010) on anxiety, depression, perceived social 
support and quality of life in breast cancer patients in 
Malaysia, showed that cancer patients with poor social 
support were associated with higher suicidal risk. The 
higher level of social support perceived among the 
breast cancer subjects was associated with better quality 
of life. Several previous studies have reported significant 
association between social support and depression (34, 
35).
III. Association between level of hopelessness and 
depression among the respondents
There was significant association between level of 
hopelessness (p<0.001) with depression in this study. 
These findings are supported by Arslan et al (2009) where 
hopelessness was proven in predicting the depression 
respectively (p= 0.01).These findings demonstrated the 
coexistence of the physical, psychological, and cognitive 
problems that are faced by cancer patients. Cancer 
patients’ psychological conditions were significantly 
impacted by depression and hopelessness (36).
Predictors of depression among the respondents
Out of the 15 risk factors (age, gender, marital status, 
family member living together, education level, stage of 
cancer, number of chemotherapy cycle, family history 
of cancer, pain due to chemotherapy, depressed due to 
cancer, treatment with any anti-depressant, worried of 
the adverse effects due to cancer treatment, joined social 
support society, level of social support and hopelessness), 
10 predictors of depression were found in this present 
study, including; age (AOR 1.539, 95% CI 01.148 to 
2.064); gender (AOR 2.004, 95% CI 1.475 to 2.725); 
education level (AOR 1.625, 95% CI 1.176 to 2.245); 
pain due to chemotherapy (AOR 2.354, 95% CI 1.708 
to 3.246); depressed due to cancer (AOR 3.369, 95% 
CI 2.402 to 4.725); treatment with any anti-depressant 
(AOR 2.244, 95% CI 1.514 to 3.328); worried of the 
adverse effects due to cancer treatment (AOR 3.232, 
95% CI 2.243 to 4.657); joined social support society 
(AOR 1.954, 95% CI 1.443 to 2.646); level of social 
support (AOR 6.680, 95% CI 4.815 to 9.269); and level 
of hopelessness (AOR 3.555, 95% CI 2.449 to 5.161). 
This present study found that the strongest predictor for 
depression among chemotherapy patients was the level 
of social support. 
CONCLUSION
This study demonstrates that depression is a major 
health concern in 10 government state hospitals in 
Peninsular Malaysia. Low level of social support was 
shown to be strongly associated with depression. This 
may be attributed to lack of awareness and lack of 
emotional and family support which will lead to suicidal 
risk. To increase the knowledge and awareness among 
the community, frequent awareness campaigns should 
be organized and health care professionals should 
encourage family members to have social support. 
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